ADC4022
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADC4022, covering 2009-03-02 to 2009-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD [Phase 2]